Exploratory study of the effect of lifestyle counselling on bone mineral density and body composition in users of the contraceptive depot-medroxyprogesterone acetate

REFERENCES

• Scholes D, La Croix AZ, Ichikawa LE, et al. Injectable hormone contraception and bone density: Results from a prospective study. Epidemiology 2002;13:581–7.
   PubMed Web of Science ®Google Scholar
• Berenson AB, Breitkopf CR, Grady JJ, et al. Effects of hormonal contraception on bone mineral density after 24 months of use. Obstet Gynecol 2004;103:899–906.
   PubMed Web of Science ®Google Scholar
• Cundy T, Cornish J, Roberts H, et al. Spinal bone density in women using depot medroxyprogesterone contraception. Obstet Gynecol 1998;92:569–73.
   PubMed Web of Science ®Google Scholar
• Scholes D, La Croix AZ, Ott SM, et al. Bone mineral density in women using depot medroxyprogesterone acetate for contraception. Obstet Gynecol 1999;93:233–8.
   PubMed Web of Science ®Google Scholar
• Berenson AB, Radecki CM, Grady JJ, et al. A prospective, controlled study of the effects of hormonal contraception on bone mineral density. Obstet Gynecol 2001; 98:576–82.
   PubMed Web of Science ®Google Scholar
• Wetmore CM, Ichikawa L, LaCroix AZ, et al. Association between caffeine intake and bone mass among young women: Potential effect modification by depot medroxyprogesterone acetate use. Osteoporos Int 2008;19:519–27.
   PubMed Web of Science ®Google Scholar
• Berenson AB, Rahman M, Breitkopf CR, et al. Effects of depot medroxyprogesterone acetate and 20-microgram oral contraceptives on bone mineral density. Obstet Gynecol 2008;112:788–99.
   PubMed Web of Science ®Google Scholar
• Clark MK, Sowers MR, Nichols S, et al. Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate. Fertil Steril 2004;82:1580–6.
   PubMed Web of Science ®Google Scholar
• Clark MK, Sowers M, Levy B, et al. Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetate. Fertil Steril 2006;86:1466–74.
   PubMed Web of Science ®Google Scholar
• Wanichsetakul P. Bone mineral density at various anatomic bone sites in women receiving combined oral contraceptives and depo-medroxyprogesterone acetate for contraception. Contraception 2002;65:407–10.
   PubMed Web of Science ®Google Scholar
• Kaunitz AM, Miller PD, Rice VM, et al. Bone mineral density in women aged 25–35 years receiving depot medroxyprogesterone acetate: Recovery following discontinuation. Contraception 2006;74:90–9.
   PubMed Web of Science ®Google Scholar
• Albertazzi P, Bottazzi M, Steel SA. Bone mineral density and depot medroxyprogesterone acetate. Contraception 2006;73:577–83.
   PubMed Web of Science ®Google Scholar
• Consensus Development Conference. Prophylaxis and treatment of osteoporosis. Osteoporos Int 1991;1:114–7.
   PubMedGoogle Scholar
• Warensjö E, Byberg L, Melhus H, et al. Dietary calcium intake and risk of fracture and osteoporosis: Prospective longitudinal cohort study. BMJ 2011;24:d1473.
   Google Scholar
• Michaëlsson K, Melhus H, Bellocco R, et al. Dietary calcium and vitamin D intake in relation to osteoporotic fracture risk. Bone 2003;32:694–703.
   PubMed Web of Science ®Google Scholar
• Feskanich D, Willett WC, Colditz GA. Calcium, vitamin D, milk consumption, and hip fractures: A prospective study among postmenopausal women. Am J Clin Nutr 2003;77:504–11.
   PubMed Web of Science ®Google Scholar
• Pludowski P, Holick MF, Pilz S, et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality – A review of recent evidence. Autoimmun Rev 2013;12:976–89.
   PubMed Web of Science ®Google Scholar
• Murad HM, Elamin KB, Abu Elnour NO, et al. The effect of vitamin D on falls: A systematic review and meta-analysis. J Clin Endocrinol Metab 2011;96:2997–3006.
   PubMed Web of Science ®Google Scholar
• Ahola R, Korpelainen R, Vainionpää A, et al. Daily impact score in long-term acceleration measurements of exercise. J Biomech 2010;43:1960–4.
   PubMed Web of Science ®Google Scholar
• Berenson AB, Rahman M. Changes in weight, total fat, percent body fat, and central-to-peripheral fat ratio associated with injectable and oral contraceptive use. Am J Obstet Gynecol 2009;200:329, e1–8.
   Google Scholar
• Clark MK, Dillon JS, Sowers M, et al. Weight, fat mass, and central distribution of fat increase when women use depot-medroxyprogesterone acetate for contraception. Int J Obes 2005;29:1252–8.
   PubMed Web of Science ®Google Scholar
• Frost HM, Schonau E. The muscle-bone unit in children and adolescents. J Pediatr Endocrinol Metab 2000;13:571–90.
   PubMed Web of Science ®Google Scholar
• Babatunde OO, Forsyth JJ. Association between depot medroxyprogesterone acetate (DMPA), physical activity and bone health. J Bone Miner Metab 2013;32:305–11.
   PubMed Web of Science ®Google Scholar